JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
PUT
Canadian Pacific Kansas City
CP
$75.1B
| $4.31M | ﹤0.01% |
56,000
+48,200
| +618% | +$3.72M |
2022 Q2
3 quarters
|
|
2827
CALL
United Therapeutics
UTHR
$23.2B
| $4.3M | ﹤0.01% |
+19,200
| New | +$4.73M |
2023 Q1
0 quarters
|
|
|
2828
PUT
United Therapeutics
UTHR
$23.2B
| $4.3M | ﹤0.01% |
+19,200
| New | +$4.73M |
2023 Q1
0 quarters
|
|
2829
PUT
Bunge Global
BG
$20.6B
| $4.3M | ﹤0.01% |
+45,000
| New | +$4.37M |
2023 Q1
0 quarters
|
|
2830
Main Street Capital
MAIN
$5.12B
| $4.29M | ﹤0.01% |
108,800
-19,793
| -15% | -$780K |
2015 Q4
29 quarters
|
|
2831
RingCentral
RNG
$6.45B
| $4.29M | ﹤0.01% |
139,888
-45,308
| -24% | -$1.62M |
2013 Q4
37 quarters
|
|
2832
Bread Financial
BFH
$3.76B
| $4.29M | ﹤0.01% |
141,429
-314,742
| -69% | -$11.8M |
2013 Q2
39 quarters
|
|
2833
Braze
BRZE
$2.99B
| $4.28M | ﹤0.01% |
123,847
+109,529
| +765% | +$3.41M |
2022 Q2
3 quarters
|
|
2834
Movado Group
MOV
$733M
| $4.28M | ﹤0.01% |
148,694
+14,684
| +11% | +$498K |
2013 Q2
39 quarters
|
|
2835
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.77B
| $4.28M | ﹤0.01% |
300,859
+104,840
| +53% | +$1.51M |
2021 Q1
8 quarters
|
|
|
NIU
2836
Niu Technologies
NIU
$151M
| $4.28M | ﹤0.01% |
1,033,177
+427,751
| +71% | +$1.98M |
2021 Q1
8 quarters
|
|
2837
Global X MLP ETF
MLPA
$2.32B
| $4.28M | ﹤0.01% |
102,773
+19,972
| +24% | +$845K |
2021 Q1
8 quarters
|
|
2838
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.94B
| $4.27M | ﹤0.01% |
169,205
+88,123
| +109% | +$2.19M |
2015 Q4
29 quarters
|
|
2839
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.03B
| $4.26M | ﹤0.01% |
70,790
+144
| +0.2% | +$8.68K |
2021 Q2
7 quarters
|
|
2840
PUT
FedEx
FDX
$68.4B
| $4.25M | ﹤0.01% |
18,600
-58,300
| -76% | -$11.8M |
2020 Q3
10 quarters
|
|
2841
Artisan Partners
APAM
$2.48B
| $4.24M | ﹤0.01% |
132,511
+21,540
| +19% | +$723K |
2017 Q1
24 quarters
|
|
2842
Ichor Holdings
ICHR
$2.34B
| $4.24M | ﹤0.01% |
129,376
+30,137
| +30% | +$967K |
2017 Q3
22 quarters
|
|
2843
Comstock Resources
CRK
$4.01B
| $4.24M | ﹤0.01% |
392,481
+219,449
| +127% | +$2.61M |
2019 Q1
16 quarters
|
|
|
UNIT
2844
Uniti Group
UNIT
$1.97B
| $4.22M | ﹤0.01% |
1,189,508
-597,080
| -33% | -$3.17M |
2015 Q2
31 quarters
|
|
|
PLL
2845
DELISTED
Piedmont Lithium
PLL
| $4.22M | ﹤0.01% |
70,233
+17,158
| +32% | +$1.04M |
2021 Q2
7 quarters
|
|
|
DNB
2846
DELISTED
Dun & Bradstreet
DNB
| $4.21M | ﹤0.01% |
358,837
+205,961
| +135% | +$2.61M |
2020 Q4
9 quarters
|
|
2847
News Corp Class B
NWS
$17B
| $4.21M | ﹤0.01% |
241,721
+123,634
| +105% | +$2.28M |
2015 Q3
30 quarters
|
|
2848
PUT
SL Green Realty
SLG
$3.43B
| $4.21M | ﹤0.01% |
+179,100
| New | +$6.04M |
2023 Q1
0 quarters
|
|
2849
Biohaven
BHVN
$1.82B
| $4.21M | ﹤0.01% |
307,967
-377,424
| -55% | -$6.01M |
2022 Q4
1 quarter
|
|
2850
iShares MSCI Kuwait ETF
KWT
$64.7M
| $4.19M | ﹤0.01% |
130,557
-37,610
| -22% | -$1.23M |
2022 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.